Stock screener

KLRA

Conviction 43HealthcareScan · Mon, Aug 10, 2026
KLRA$18.97+1.63%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 540.15K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Kailera Therapeutics, Inc.Biotechnologywww.kailera.com
Price18.97
Change+1.63%
Gap+2.14%
Rel volume3.45×
Avg volume485.05K
Avg $ vol8.71M
SMA 2017.98
SMA 5019.76
SMA 200
Price vs 50-4.00%
Price vs 200
MA stack
50/200 cross
Supertrenddown · 20.96
RSI (14)52
MACD hist0.28
MACD crossbull · 4d
Stoch %K / %D89 / 88
ADX (14)21
+DI / −DI19 / 14
RSI divergence
MACD divergence
ATR %+6.32%
ADR %6.15%
52w high26.00
52w low16.74
From 52w high-27.06%
Above 52w low+13.29%
New 52w highNo
SqueezeOff
Bollinger width16.91%
%B0.82
Donchian pos69.41%
Donchian high20.10
Donchian low16.39
AVWAP (52w high)21.23
vs AVWAP high-10.66%
AVWAP (52w low)18.25
vs AVWAP low+3.91%
OBV trendFlat
Chaikin MF (20)0.00
Today vs 20d3.45×
Avg vol (14d)540.15K
Avg vol (20d)485.05K
Avg $ vol (20d)8.71M
Market cap2.46B
RS 3m (vs SPY)-22.65%
RS 6m (vs SPY)
RS line new highNo
Trend template
Technical rank31.2
1 week+9.50%
1 month-8.29%
3 months-11.67%
6 months
1 year
YTD-27.06%
P/E
P/B-5.69
P/S
P/FCF
EPS
Div yield
ROE
ROA
Debt/Eq
Current9.67
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth
Price target45.00
Target upside137.28%
Analyst ratingBuy
Institutional3.77%
Ent. value2.35B
Revenue
Net income-78.86M
Gross profit
Free cash flow
IndustryBiotechnology
ExchangeNasdaq
Shares out129.57M
Employees
ListedFri, Apr 17, 2026
Free float53.4M
Float %41.2%
Short interest6.41M
Days to cover9.3d
Short volume91.0%
Squeeze score84 / 100
Next earnings
EPS forecast
Last EPS vs est−$3650.00
Last surprise
Setup gradeD
Conviction43 / 100
Pattern quality
Tech rank31.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance23.38
Support17.45
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KLRA

All disclosures →
No recent disclosed trades by Congress in KLRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KLRA · 5 buys · 4 sells

InsiderSideShares
Tregoning Kathleen
See Remarks · Stock Option (right to buy) · 2026-07-06
Grant175K
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner · Common Stock · 2026-04-20
Convert9.48M
WONG RODERICK
10% owner · Common Stock · 2026-04-20
Buy500K
RTW INVESTMENTS, LP
10% owner · Series B Preferred Stock · 2026-04-20
Convert2.03M
RTW INVESTMENTS, LP
10% owner · Series A Preferred Stock · 2026-04-20
Convert8.25M
WONG RODERICK
10% owner · Series B Preferred Stock · 2026-04-20
Convert2.03M
RTW INVESTMENTS, LP
10% owner · Common Stock · 2026-04-20
Buy500K
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner · Common Stock · 2026-04-20
Other
RTW INVESTMENTS, LP
10% owner · Common Stock · 2026-04-20
Convert10.28M
WONG RODERICK
10% owner · Series A Preferred Stock · 2026-04-20
Convert8.25M

SEC filings

EDGAR filings in KLRA · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.